extended and expanded its current research collaboration with Ono
Pharmaceutical. The firm will provide additional activities including high-throughput screening, medicinal chemistry, and in vitro pharmacology to find novel, small molecular weight compounds active against an ion channel target selected by Ono. Ono will provide research funding and milestone payments.
Evotec and Ono have collaborated since March 2008, identifying novel inhibitors for a protease target. Within this collaboration, Evotec provides protein crystallography, medicinal chemistry, biology, and ADMET services to Ono with the aim of progressing a compound toward clinical development.